Table 5.
MICs for receptor mutants and complemented PAO1 strains
| Strain | MIC (μg/ml)a |
||
|---|---|---|---|
| BAL | ATM | BAL + 0.25 mM BPLb | |
| PT5 (PAO1) | 1 | 4 | 0.5 |
| BAL6 | 32 | 4 | 16 |
| PAO1(pIApX2) | 1 | 4 | 0.5 |
| PAO1(pfecI) | 32 | 2 | 16 |
| PAO1(pfecA) | 8 | 2 | 1 |
| MPAO1fecA(pIApX2) | <0.06 | 2 | ND |
| MPAO1fecA (pfecI) | <0.06 | 4 | ND |
| MPAO1fecA (pfecA) | 8 | 4 | ND |
| MPAO1fecI | <0.06 | 4 | ND |
| MPAO1piuA | 8–16 | 8 | 8 |
| MPAO1piuC | 16 | 4 | 8 |
| MPAO1femA | 1 | 4 | 0.5 |
| MPAO1pfuA | 1 | 4 | 0.5 |
| MPAO1fiuA | 1 | 4 | 0.5 |
| PAO1furA4 | <0.06 | 2 | ND |
| PAO1ΔfptA | 1 | 4 | 1 |
| PAO1ΔpchR | 1 | 4 | 1 |
a
The MICs for strain MPAO1 were identical to those for PAO1 strain PT5.
b
BPL, 2,2′-bipyridyl. ND, not determined.